Nanobac Ev To Operating Cash Flow vs Capex To Revenue Analysis
| NNBP Stock | USD 0.0001 0.00 0.00% |
Nanobac Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Nanobac Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanobac Pharmaceuticals is a good investment. Please check the relationship between Nanobac Pharmaceuticals Ev To Operating Cash Flow and its Capex To Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Ev To Operating Cash Flow vs Capex To Revenue
Ev To Operating Cash Flow vs Capex To Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanobac Pharmaceuticals Ev To Operating Cash Flow account and Capex To Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Nanobac Pharmaceuticals' Ev To Operating Cash Flow and Capex To Revenue is 0.78. Overlapping area represents the amount of variation of Ev To Operating Cash Flow that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Nanobac Pharmaceuticals Incorporated, assuming nothing else is changed. The correlation between historical values of Nanobac Pharmaceuticals' Ev To Operating Cash Flow and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Operating Cash Flow of Nanobac Pharmaceuticals Incorporated are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ev To Operating Cash Flow i.e., Nanobac Pharmaceuticals' Ev To Operating Cash Flow and Capex To Revenue go up and down completely randomly.
Correlation Coefficient | 0.78 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Ev To Operating Cash Flow
A valuation metric comparing the company's enterprise value to its operating cash flow, indicating how many dollars of EV are generated for each dollar of operating cash flows.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most indicators from Nanobac Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanobac Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nanobac Pharmaceuticals Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. As of 11/30/2024, Selling General Administrative is likely to drop to about 2.6 M. In addition to that, Discontinued Operations is likely to drop to about (54.1 K)
| 2010 | 2011 | 2023 | 2024 (projected) | Gross Profit | 8K | 3.1K | 3.6K | 3.4K | Total Revenue | 12K | 17.6K | 15.9K | 15.1K |
Nanobac Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Nanobac Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.